| Q42357138 | A study of Ki-67 expression and its clinicopathological determinants in nondysplastic oral leukoplakia |
| Q27324837 | Accuracy of autofluorescence in diagnosing oral squamous cell carcinoma and oral potentially malignant disorders: a comparative study with aero-digestive lesions |
| Q36919667 | Aetiology and risk factors for head and neck cancer: United Kingdom National Multidisciplinary Guidelines |
| Q42119241 | Between-lesion discrepancies in terms of dysplasia, cell turnover and diagnosis in patients with multiple potentially malignant oral lesions |
| Q26774585 | Biomarkers in phase I-II chemoprevention trials: lessons from the NCI experience |
| Q52678809 | Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine. |
| Q57821380 | Chemoprevention of Head and Neck Cancers: Does It Have Only One Face? |
| Q92598880 | Clincopathological characteristics and treatment outcomes of oral leukoplakia by carbon dioxide laser excision in the elderly patients |
| Q34917447 | Clinical outcome following oral potentially malignant disorder treatment: a 100 patient cohort study |
| Q57288208 | Comparative evaluation of autofluorescence imaging and histopathological investigation for oral potentially malignant disorders in Taiwan |
| Q59810630 | Correlation of matrix metalloproteinase-9 expression with morphometric analysis of mucosal vasculature in oral squamous cell carcinoma, oral epithelial dysplasia, and normal oral mucosa |
| Q37631304 | Current views and perspectives on classification of squamous intraepithelial lesions of the head and neck |
| Q89533261 | DNA aneuploidy and tissue architecture in oral potentially malignant disorders with epithelial dysplasia assessed by a 10 locus FISH panel |
| Q38376361 | DNA damage marker phosphorylated histone H2AX is a potential predictive marker for progression of epithelial dysplasia of the oral cavity |
| Q26774115 | DNA methylation markers for oral pre-cancer progression: A critical review |
| Q34652780 | Diagnostic aids for detection of oral precancerous conditions |
| Q24187750 | Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions |
| Q38612022 | Efficacy of Oral Brush Biopsy in Potentially Malignant Disorder Management |
| Q26852167 | Epidemiologic trends in head and neck cancer and aids in diagnosis |
| Q100532898 | Epithelial Distribution of E-Cadherin, p63, and Mitotic Figures in ApoTome Images to Determine the Oncogenic Potentiality of Oral Submucous Fibrosis |
| Q52716444 | Evaluation of Collagen in Leukoplakia, Oral Submucous Fibrosis and Oral Squamous Cell Carcinomas Using Polarizing Microscopy and Immunohistochemistry |
| Q39728272 | Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. |
| Q42326713 | Feasibility of recruitment to an oral dysplasia trial in the United Kingdom |
| Q37150006 | Fluorescence Identification of Head and Neck Squamous Cell Carcinoma and High-Risk Oral Dysplasia With BLZ-100, a Chlorotoxin-Indocyanine Green Conjugate |
| Q37850474 | Genetics/epigenetics of oral premalignancy: current status and future research |
| Q61815667 | Human papillomavirus in premalignant oral lesions: No evidence of association in a Spanish cohort |
| Q38674897 | In silico analysis of pathways activation landscape in oral squamous cell carcinoma and oral leukoplakia |
| Q36091484 | In vivo layer-resolved characterization of oral dysplasia via nonlinear optical micro-spectroscopy |
| Q34009983 | Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study |
| Q28277102 | Independent evaluation of a FOXM1-based quantitative malignancy diagnostic system (qMIDS) on head and neck squamous cell carcinomas |
| Q49499911 | Inter- and Intra-Observer Variability in Diagnosis of Oral Dysplasia |
| Q42246544 | Investigation of p16(INK4a) as a prognostic biomarker in oral epithelial dysplasia |
| Q40640562 | Lesion Evaluation, Screening and Identification of Oral Neoplasia Study: an assessment of high-risk Australian populations. |
| Q36029427 | Leukoplakia, Oral Cavity Cancer Risk, and Cancer Survival in the U.S. Elderly. |
| Q59104287 | Malignant Transformation Rate in Patients Presenting Oral Epithelial Dysplasia: Systematic Review and Meta-Analysis |
| Q34632270 | Malignant transformation of oral leukoplakia in a well-defined cohort of 144 patients. |
| Q38550129 | Malignant transformation of oral leukoplakia: a systematic review of observational studies |
| Q39371584 | Meta-analysis of the predictive value of DNA aneuploidy in malignant transformation of oral potentially malignant disorders. |
| Q42388428 | MicroRNAs-208b-3p, 204-5p, 129-2-3p and 3065-5p as predictive markers of oral leukoplakia that progress to cancer |
| Q47666496 | Mouth Cancer for Clinicians Part 13: Life After Mouth Cancer Treatment |
| Q38691624 | Mouth Cancer for Clinicians Part 6: Potentially Malignant Disorders |
| Q50336126 | New developments in the management of head and neck cancer – impact of pembrolizumab |
| Q60406722 | Noninvasive diagnostic adjuncts for the evaluation of potentially premalignant oral epithelial lesions: current limitations and future directions |
| Q35251675 | Notch1 mutations are drivers of oral tumorigenesis |
| Q33661428 | Oral cancer and oral potentially malignant disorders |
| Q34238689 | Oral cancer development in patients with leukoplakia--clinicopathological factors affecting outcome |
| Q83242624 | Oral dysplasia: biomarkers, treatment, and follow-up |
| Q64242260 | Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders |
| Q47665597 | Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners |
| Q38806411 | Oral malignancy and premalignancy. |
| Q27693327 | Oral premalignancy: the roles of early detection and chemoprevention |
| Q33896090 | PPARγ in head and neck cancer prevention |
| Q47659277 | Phospholipase C-γ1 expression correlated with cancer progression of potentially malignant oral lesions |
| Q38006577 | Photodynamic therapy in the management of potentially malignant and malignant oral disorders |
| Q36687568 | Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma |
| Q33849082 | Photodynamic therapy outcome for oral dysplasia |
| Q38147577 | Photodynamic therapy: a review and its prospective role in the management of oral potentially malignant disorders |
| Q89595240 | Point-of-care oral cytology tool for the screening and assessment of potentially malignant oral lesions |
| Q91714008 | Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype |
| Q38183795 | Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory |
| Q48191557 | Potentially malignant disorders-The case for intervention |
| Q58116246 | Predicting malignant progression in clinically high-risk lesions by DNA ploidy analysis and dysplasia grading |
| Q92656022 | Predictive value of CCND1/cyclin D1 alterations in the malignant transformation of potentially malignant head and neck disorders: Systematic review and meta-analysis |
| Q96643537 | Prevalence of human papillomavirus in oral epithelial dysplasia: Systematic review and meta-analysis |
| Q48191368 | Profiling cancer risk in oral potentially malignant disorders-A patient cohort study |
| Q90610936 | Quantification of structural and microvascular changes for diagnosing early-stage oral cancer |
| Q39603028 | Recurrence patterns of oral leukoplakia after curative surgical resection: important factors that predict the risk of recurrence and malignancy |
| Q91760284 | Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study |
| Q48151447 | Risk analysis of malignant potential of oral verrucous hyperplasia: A follow-up study of 269 patients and copy number variation analysis. |
| Q43972741 | S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia |
| Q47252834 | SUOX is negatively associated with multistep carcinogenesis and proliferation in oral squamous cell carcinoma |
| Q38271720 | Screening for oral cancer: contributing to the debate |
| Q30240178 | Smokeless Tobacco and Oral Potentially Malignant Disorders in South Asia: A Systematic Review and Meta-analysis. |
| Q37203473 | Smokeless tobacco and oral potentially malignant disorders in South Asia: a protocol for a systematic review |
| Q37903902 | Squamous cell carcinoma and precursor lesions: prevention |
| Q35963741 | Targeting of chemoprevention to high-risk potentially malignant oral lesions: challenges and opportunities |
| Q37352556 | Tetraspanins CD9 and CD151, epidermal growth factor receptor and cyclooxygenase-2 expression predict malignant progression in oral epithelial dysplasia. |
| Q35669976 | The clonal relationships between pre-cancer and cancer revealed by ultra-deep sequencing |
| Q90087714 | The efficacy of photodynamic therapy in rat tongue dysplasia |
| Q42217525 | The genomic road to invasion-examining the similarities and differences in the genomes of associated oral pre-cancer and cancer samples |
| Q84230286 | The identification of significant chromosomal regions correlated with oral tongue cancer progression |
| Q33756035 | The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and meta‐analysis |
| Q38245660 | The use of light-based (optical) detection systems as adjuncts in the detection of oral cancer and oral potentially malignant disorders: a systematic review |
| Q44100456 | Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial |
| Q48097103 | Treatment resistance in potentially malignant disorders-'Nature' or 'Nurture'…? |
| Q35580648 | Two distinct routes to oral cancer differing in genome instability and risk for cervical node metastasis. |
| Q47161140 | Type of surgical treatment and recurrence of oral leukoplakia: A retrospective clinical study. |
| Q34326109 | Urban legends series: oral leukoplakia. |
| Q36213589 | Validation of LOH profiles for assessing oral cancer risk. |